Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Guardant Health Inc before investing.

In this article, we go over a few key elements for understanding Guardant Health Inc’s stock price such as:

• Guardant Health Inc’s current stock price and volume
• Why Guardant Health Inc’s stock price changed recently
• Upgrades and downgrades for GH from analysts
• GH’s stock price momentum as measured by its relative strength

About Guardant Health Inc (GH)

Before we jump into Guardant Health Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 TissueNext tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

Want to learn more about Guardant Health Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Guardant Health Inc.

Guardant Health Inc’s Stock Price as of Market Close

As of June 06, 2024, 3:59 PM, CST, Guardant Health Inc’s stock price was $29.02.

Guardant Health Inc is down 6.96% from its previous closing price of $31.19.

During the last market session, Guardant Health Inc’s stock traded between $27.33 and $32.30. Currently, there are 121.71 million shares of Guardant Health Inc stock available for purchase.

Unfortunately, Guardant Health Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Guardant Health Inc Stock Price History

Guardant Health Inc’s (GH) price is currently up 7.08% so far this month.

During the month of June, Guardant Health Inc’s stock price has reached a high of $32.30 and a low of $26.38.

Over the last year, Guardant Health Inc has hit prices as high as $41.06 and as low as $15.81. Year to date, Guardant Health Inc’s stock is up 6.69%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Guardant Health Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 05, 2024, there was 1 analyst who downgraded Guardant Health Inc’s stock and 15 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Guardant Health Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Guardant Health Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Guardant Health Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Guardant Health Inc (GH) by visiting AAII Stock Evaluator.

Relative Price Strength of Guardant Health Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 05, 2024, Guardant Health Inc has a weighted four-quarter relative price strength of 13.04%, which translates to a Momentum Score of 90 and is considered to be Very Strong.

Want to learn more about how Guardant Health Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Guardant Health Inc Stock Price: Bottom Line

As of June 6, 2024, Guardant Health Inc’s stock price is $29.02, which is down 6.96% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Guardant Health Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.